SF Healthcare Week: Flagship Pioneering's Noubar Afeyan on Moderna, gov't policy, China, and "polyintelligence" in drug development
He shares his thoughts on Moderna's transition, what policies he would like to see promoted in government, competing with China, and the multitude of factors (AI, human intelligence, nature) that must be included in the drug development process.
